Medical Cannabis for Pain Management: Nursing Roles
Keywords:
medical cannabis, pain management, nursing rolesAbstract
Nowadays, medical cannabis is being used for pain management. However, there is conflicting evidence regarding the use of medical cannabis for pain management. Nurses are key health personnel in pain management practices. Moreover, the use of medical cannabis is new for Thai nurses. Nurses working in pain management practices that are using medical cannabis must have a thorough understanding of the use of medical cannabis for pain management. The purpose of this article was to review cannabis for medical purposes, with an emphasis on pain management and focusing on content related to the mechanisms of action of the cannabis on the systems in the body, the pharmacology of cannabis, research on the use of cannabis in pain management, the nurse’s role in pain management, and the integration of research into clinical practice. This research will support the patients to be able to confidently disclose cannabis use and engage in shared decisions about its potential effects on their health.
References
Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics 2017;42:180.
สำนักงานคณะกรรมการอาหารและยา กองควบคุมวัตถุเสพติด กระทรวงสาธารณสุข. พระราชบัญญัติยาเสพติดให้โทษ (ฉบับที่ 7) พ.ศ. 2562 (ประกาศในราชกิจจานุเบกษา เมื่อวันที่ 18 กุมภาพันธ์ 2562) [อินเตอร์เน็ต]. 2562 [เข้าถึงเมื่อ 17 เม.ย. 2564]. เข้าถึงได้จาก: https://mnfda.fda.moph.go.th/narcotic/?p=3914
McPartland JM. Cannabis systematics at the levels of family, genus, and species. Cannabis and cannabinoid research 2018;3:203-12.
Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, et al. Antibacterial cannabinoids from Cannabis sativa: a structure− activity study. Journal of natural products 2008;71:1427-30.
Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products–Regulations in Europe and North America. European journal of internal medicine 2018;49:2-6.
Iseger TA, Bossong MG. A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophrenia research 2015;162:153-61.
Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, et al. Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. Journal of Psychopharmacology 2014;28:1088-98.
Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, et al. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacology & therapeutics 2017;175:133-50.
Janero DR, Makriyannis A. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert opinion on emerging drugs 2009;14:43-65.
Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacological Research 2009;60:77-84.
Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of psychopharmacology. 2012;26:114-24.
Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, et al. Crystal structure of the human cannabinoid receptor CB1. Cell. 2016;167:750-62. e14.
Fonseca B, Costa M, Almada M, Correia-da-Silva G, Teixeira N. Endogenous cannabinoids revisited: a biochemistry perspective. Prostaglandins & other lipid mediators 2013;102:13-30.
Zogopoulos P, Vasileiou I, Patsouris E, Theocharis SE. The role of endocannabinoids in pain modulation. Fundamental & clinical pharmacology 2013;27:64-80.
Martin JH, Schneider J, Lucas CJ, Galettis P. Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction? Clinical pharmacokinetics 2018;57:539-45.
Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug metabolism reviews 2014;46:86-95.
Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F. The medicinal use of cannabis and cannabinoids—an international cross-sectional survey on administration forms. Journal of psychoactive drugs 2013;45:199-210.
Sharma P, Murthy P, Bharath MS. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iranian Journal of Psychiatry 2012;7:149.
Loflin MJ, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and alcohol dependence 2020:107993.
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis‐based medicines for chronic neuropathic pain in adults. Cochrane Cochrane Database Syst Rev 2018;3:CD012182. doi: 10.1002/14651858.CD012182.pub2.
Ablin J, Ste-Marie P, Schäfer M, Häuser W, Fitzcharles M-A. Medical use of cannabis products. Der Schmerz 2016;30:3-13.
Clem SN, Bigand TL, Wilson M. Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction. Pain Management Nursing 2020;21:43-7.
De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain 2019;160:136.
Hill KP. Medical use of cannabis in 2019. Jama 2019;322:974-5.
Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain 2018;159:1932-54.
Hordowicz M, Klimkiewicz A, Jarosz J, Wysocka M, Jastrzębska M. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review. Drug and Alcohol Dependence 2021:222;108652. doi: https://doi.org/10.1016/j.drugalcdep.2021.108652.
Palace ZJ, Reingold DA. Medical cannabis in the skilled nursing facility: A novel approach to improving symptom management and quality of life. Journal of the American Medical Directors Association 2019;20:94-8.
Wilson M, Klein T, Bindler RJ, Kaplan L. Shared Decision-Making for Patients Using Cannabis for Pain Symptom Management in the United States. Pain Management Nursing 2020:22;15-20. doi: https://doi.org/10.1016/j.pmn.2020.09.009.
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารวิทยาศาสตร์สุขภาพ วิทยาลัยพยาบาลบรมราชชนนี สรรพสิทธิประสงค์ ข้อความที่ปรากฏในบทความแต่ละเรื่องเป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับวิทยาลัยพยาบาลบรมราชชนนี สรรพสิทธิประสงค์ และคณาจารย์ท่านอื่นๆ ในวิทยาลัยพยาบาลฯ ความรับผิดชอบเกี่ยวกับบทความแต่ละเรื่องผู้เขียนจะรับผิดชอบของตนเอง
